BIOSIGNIA

Development of new technology for others for accurate chronic disease prediction and economic impact modeling, namely, development of comprehensive computer software programs that augment decisions related to patient care, clinical research and actuarial sciences which determine the risk of morbidity and/or mortality, namely statistical software tools that predict the risk of disease onset or death from disease